TerminatedPhase 3NCT04634604
A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
Studying Retinopathy of prematurity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jaeb Center for Health Research
- Principal Investigator
- David K Wallace, MD, MPHIndiana University
- Intervention
- Bevacizumab(drug)
- Enrollment
- 16 target
- Eligibility
- All sexes
- Timeline
- 2022 – 2023
Study locations (30)
- Arizonia Pediatric Eye Specialists, Phoenix, Arizona, United States
- Arkansas Childrens Hospital/ University of Arkansas Medical Sciences, Little Rock, Arkansas, United States
- Univ of California, Irvine- Gavin Herbert Eye Institute, Irvine, California, United States
- University of California, Davis, Sacramento, California, United States
- University of California San Francisco Department of Ophthalmology, San Francisco, California, United States
- University of Colorado Health Sciences Center, Aurora, Colorado, United States
- Denver Health and Hospital Authority, Denver, Colorado, United States
- Connecticut Childrens Medical Center, Farmington, Connecticut, United States
- The Emory Eye Center, Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- U of Illinois at Chicago Eye and Ear Infirmary, Chicago, Illinois, United States
- University of Chicago, Hyde Park, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- UK Ophthalmology and Visual Sciences, The Eye Clinic, Lexington, Kentucky, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Pediatric Eye Disease Investigator Group · National Eye Institute (NEI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04634604 on ClinicalTrials.govOther trials for Retinopathy of prematurity
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07093255Safety, PK and PD of FLQ-101 in Premature NeonatesFELIQS INC.
- RECRUITINGNCT06612541Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of PrematurityVanderbilt University Medical Center
- ENROLLING BY INVITATIONNANCT07334652Pain and Comfort in the Examination of Retinopathy of PrematurityAtaturk University
- RECRUITINGNANCT06717412Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity TherapyWang Yusheng
- RECRUITINGNCT05558059Imaging Retinal Vasculature in Infant EyesDuke University
- ACTIVE NOT RECRUITINGNANCT06109285Validation of i-ROP DL to Detect More Than Mild ROPSiloam Vision
- RECRUITINGNCT06315556An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)Bayer
- RECRUITINGNANCT06694103The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy ExaminationSinem Basdemir